M
Michael Dean
Researcher at National Institutes of Health
Publications - 44
Citations - 1186
Michael Dean is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 11, co-authored 44 publications receiving 536 citations. Previous affiliations of Michael Dean include California Health and Human Services Agency.
Papers
More filters
Journal ArticleDOI
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma.
Yun-Fan Sun,Liang Wu,Liang Wu,Yu Zhong,Kai-Qian Zhou,Yong Hou,Zifei Wang,Ze-Fan Zhang,J. Xie,Chunqing Wang,Dandan Chen,Yaling Huang,Xiaochan Wei,Ying-Hong Shi,Zhikun Zhao,Yue-Hua Li,Zi-Wei Guo,Qichao Yu,Liqin Xu,Giacomo Volpe,Shuang-Jian Qiu,Jian Zhou,Carl Ward,Hui-Chuan Sun,Ye Yin,Xun Xu,Xiangdong Wang,Miguel A. Esteban,Huanming Yang,Jian Wang,Michael Dean,Yaguang Zhang,Shiping Liu,Xin-Rong Yang,Jia Fan +34 more
TL;DR: A comprehensive picture of the HCC ecosystem provides deeper insights into immune evasion mechanisms associated with tumor relapse, including those that dampen DC antigen presentation and recruit innate-like CD8+ T cells.
Journal ArticleDOI
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma.
Yu Pei Chen,Jianhua Yin,Wen-Fei Li,Hanjie Li,Dong-Ping Chen,Cui-Juan Zhang,Jia-Wei Lv,Ya-Qin Wang,Xiao-Min Li,Jun-Yan Li,Pan-Pan Zhang,Ying-Qin Li,Qingmei He,Xiao-Jing Yang,Yuan Lei,Ling-Long Tang,Guan-Qun Zhou,Yan Ping Mao,Chen Wei,Ke-Xu Xiong,Hong-Bo Zhang,Shida Zhu,Yong Hou,Ying Sun,Michael Dean,Ido Amit,Kui Wu,Dong-Ming Kuang,Guibo Li,Na Liu,Jun Ma +30 more
TL;DR: This work generated single-cell transcriptome profiles for 7581 malignant cells and 40,285 immune cells from fifteen primary NPC tumors and one normal sample and established the immune subtype-specific signatures, demonstrating that the signatures of macrophages, plasmacytoid dendritic cells (pDCs), CLEC9A+ DCs, natural killer cells, and plasma cells were significantly associated with improved survival outcomes in NPC.
Journal ArticleDOI
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Lisa Mirabello,Bin Zhu,Roelof Koster,Eric Karlins,Michael Dean,Meredith Yeager,Matthew Gianferante,Logan G. Spector,Lindsay M. Morton,Danielle M. Karyadi,Leslie L. Robison,Gregory T. Armstrong,Smita Bhatia,Lei Song,Nathan Pankratz,Maisa Pinheiro,Julie M. Gastier-Foster,Richard Gorlick,Silvia Regina Caminada de Toledo,Antonio Sergio Petrilli,Ana Patiño-García,Fernando Lecanda,Miriam Gutiérrez-Jimeno,Massimo Serra,Claudia Maria Hattinger,Piero Picci,Katia Scotlandi,Adrienne M. Flanagan,Roberto Tirabosco,Maria Fernanda Amary,Nilgun Kurucu,Inci Ergurhan Ilhan,Mandy L. Ballinger,Mandy L. Ballinger,David Thomas,David Thomas,Donald A. Barkauskas,Gerardo Mejia-Baltodano,Patricia Valverde,Belynda Hicks,Mingyi Wang,Amy Hutchinson,Margaret A. Tucker,Joshua N. Sampson,Maria Teresa Landi,Neal D. Freedman,Susan M. Gapstur,Brian D. Carter,Robert N. Hoover,Stephen J. Chanock,Sharon A. Savage +50 more
TL;DR: About one-fourth of patients with osteosarcoma unselected for family history had a highly penetrant germline mutation requiring additional follow-up analysis and possible genetic counseling with cascade testing.
Journal ArticleDOI
HIV-1 Infection in Individuals With the CCR5-Δ32/Δ32 Genotype: Acquisition of Syncytium-Inducing Virus at Seroconversion
Haynes W. Sheppard,Connie Celum,Nelson L. Michael,Stephen J. O'Brien,Michael Dean,Mary Carrington,Dale Dondero,Susan Buchbinder +7 more
TL;DR: The results further support the conclusion that Delta32-mediated resistance is incomplete and is associated with acquisition of exclusively-X4 variants of HIV-1.
Journal ArticleDOI
Phenotypic expressions of CCR5-Δ32/Δ32 homozygosity
GT Nguyen,Mary Carrington,JA Beeler,Michael Dean,Louis M. Aledort,Philip M. Blatt,Alan R. Cohen,Donna DiMichele,M. E. Eyster,Craig M. Kessler,Barbara A. Konkle,Cindy A. Leissinger,Naomi L.C. Luban,Stephen J. O'Brien,Goedert Jj,Thomas R. O'Brien +15 more
TL;DR: CCR5-Delta 32/Delta 32 homozygosity does not provide broad protection against viral infections, and the prevalence of antibodies to nine other common viruses, HBV, and HCV was not related to CCR5 genotype.